Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk
other	Dyspepsia	Gastrointestinal disorders	Ibandronate	12	640
other	Nausea	Gastrointestinal disorders	Ibandronate	7	640
serious	Pericarditis	Cardiac disorders	Ibandronate	1	640
serious	Iridocyclitis	Eye disorders	Ibandronate	1	640
serious	Abdominal pain upper	Gastrointestinal disorders	Ibandronate	1	640
serious	Hiatus hernia	Gastrointestinal disorders	Ibandronate	1	640
serious	Pyrexia	General disorders	Ibandronate	1	640
serious	Postoperative hernia	Injury, poisoning and procedural complications	Ibandronate	1	640
serious	Bone pain	Musculoskeletal and connective tissue disorders	Ibandronate	1	640
serious	Renal failure acute	Renal and urinary disorders	Ibandronate	1	640
serious	Pulmonary embolism	Respiratory, thoracic and mediastinal disorders	Ibandronate	1	640

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00545779/events